Ketone bodies in right ventricular failure: A unique therapeutic opportunity-Reference-Cited by-同舟云学术

Ketone bodies in right ventricular failure: A unique therapeutic opportunity

Published:2023-11 Issue:11 Volume:9 Page:e22227
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Blake Madelyn^ORCID,Puchalska Patrycja,Kazmirczak Felipe,Blake Jeffrey,Moon Ryan,Thenappan Thenappan^ORCID,Crawford Peter A.^ORCID,Prins Kurt W.^ORCID

Funder

National Heart, Lung, and Blood Institute

National Institutes of Health

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference19 articles.

1. Right ventricular failure;Houston;N. Engl. J. Med.,2023

2. 2022 AHA/ACC/HFSA guideline for the management of heart failure: executive summary: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines;Heidenreich;Circulation,2022

3. Treatment targets for right ventricular dysfunction in pulmonary arterial hypertension;Prisco;JACC Basic Transl Sci,2020

4. Systemic consequences of pulmonary hypertension and right-sided heart failure;Rosenkranz;Circulation,2020

5. Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics;Puchalska;Cell Metabol.,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An exercise in relaxation: right ventricular diastolic function predicts exercise capacity in pulmonary arterial hypertension;European Respiratory Journal;2024-07

2. Noninvasive assessment of liver stiffness in right heart failure: A new phenotype requiring further exploration;The Journal of Heart and Lung Transplantation;2024-07

3. Extrapulmonary manifestations of pulmonary arterial hypertension;Expert Review of Respiratory Medicine;2024-04-02

4. The therapeutic potential of ketones in cardiometabolic disease: impact on heart and skeletal muscle;American Journal of Physiology-Cell Physiology;2024-02-01